Scott Turner, a New Hampshire medical marijuana patient who made headlines during the presidential primaries when he got then-Sen. Obama to promise to end federal interference in medical marijuana states, died Aug. 4.

Scott, who suffered a long, painful battle with degenerative joint disease and a degenerative disc disease, was a great friend to MPP and a tireless advocate for the rights of patients to use medical marijuana without fear of arrest.

Most recently, he was involved in the fight to pass a medical marijuana bill in New Hampshire, which was vetoed by the governor after legislators scrambled to pass a bill they had reworked to his specifications.

We here at MPP will miss Scott dearly, and we offer our sincerest condolences to his wife and family. We’ll continue your work, Scott, and make sure the New Hampshire legislature overrides Gov. Lynch’s veto and ensures no seriously ill Granite Stater ever has to endure what you endured just to treat your pain.

Here’s Scott back in August 2007, securing Obama’s support for the rights of medical marijuana patients, which led the Obama administration to announce its historic policy change earlier this year:

Share/Bookmark

British scientists warn increasing hostility toward scientific evidence that contradicts political agendas could hinder the collaborative relationship policy and science enjoys in Britain, the Guardian reported yesterday.

Last November, the British government ignored the advice of its Scientific Advisory Board and moved marijuana into a more dangerous class of drugs, a move described by top scientists at the time as “a sad departure from the welcome trend … of public policy following expert scientific advice.”

Of course, here in the United States, government has been ignoring its scientific advisors on marijuana policy for decades, at least since Nixon first lined his bird cage with the two-year study he commissioned recommending marijuana’s decriminalization.

And that unwelcome trend continues to this very day here, as evidenced by drug czar Gil Kerlikowske’s recent lie that marijuana “has no medicinal benefit.” Not sure who Kerlikowske’s scientific advisors are, but the one we taxpayers use, the National Academy of Sciences’ Institute of Medicine, says: “Nausea, appetite loss, pain, and anxiety … all can be mitigated by marijuana.”

Then again, it doesn’t take a scientist to know that it’s wrong to deny sick people medicine that eases their pain, or to arrest responsible adults because they prefer a drug that’s safer than alcohol or tobacco.

Share/Bookmark

Okay, let me say right up front that a) I know that headline is provocative, and b) neither I nor anyone can answer the question with any certainty given what we know and don’t know so far about Michael Jackson’s death. But the question needs to be asked.

It needs to be asked because suspicions that prescription painkillers may have been involved in Jackson’s death are strong enough that the federal Drug Enforcement Administration has been brought into the investigation. And we know that he had a documented history of battling pain and at least some acknowledged problems with prescription painkillers.

We don’t know yet what pain drugs Jackson was on or what they were prescribed for. But if he was addicted to prescription painkillers, that addiction almost certainly started with legitimate and needed treatment for real pain. And that’s where medical marijuana might have helped. [Read more →]

Share/Bookmark

For the first time in my life, I’ve just been prescribed an opioid painkiller: hydrocodone/acetaminophen, commonly known by the brand name Vicodin. The occasion was a medical procedure known as brachytherapy. I’ll explain more about that below, but it’s pretty low on the fun meter. There can be lingering pain for a few days, hence my introduction into the fabulous world of narcotic pain drugs.

I can’t help but notice some odd contrasts with medical marijuana. [Read more →]

Share/Bookmark

There is evidence that marijuana may work synergistically with opioid pain drugs, allowing equal or better relief with reduced doses of narcotics and reduced development of tolerance to the drugs. But most of this evidence comes from animal studies, so data from human clinical trials is urgently needed.

Dr. Donald Abrams of the University of California, San Francisco, is doing just such a study right now and needs volunteers who are suffering from chronic pain and currently taking OxyContin or MS Contin. Compensation and assistance with transportation to San Francisco are available. If you or anyone you know might be eligible to participate, please check out the details here and consider joining this important effort.

Share/Bookmark